Zhenchuan Liu

1.1k total citations · 1 hit paper
16 papers, 694 citations indexed

About

Zhenchuan Liu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhenchuan Liu has authored 16 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Zhenchuan Liu's work include RNA modifications and cancer (10 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Zhenchuan Liu is often cited by papers focused on RNA modifications and cancer (10 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Zhenchuan Liu collaborates with scholars based in China and United States. Zhenchuan Liu's co-authors include Yongxin Zhou, Shaorui Gu, Chenglai Dong, Kaiqing Wu, Yunlang She, Lei Li, Tingting Wang, Chang Chen, Tiancheng Lu and Wenli Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and Molecular Cancer.

In The Last Decade

Zhenchuan Liu

15 papers receiving 685 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer

2021 267 citations Zhenchuan Liu, Tingting Wang et al. Molecular Cancer profile →

Peers

Zhenchuan Liu

ONCOL

IMMUN

PRM

Haiwen Ma China

Cristina Caffarra Italy

Daixing Zhong China

Xiaoling Qiu China

Zhongjie Lin China

Zhenhua Chen China

Yixiao Yuan China

Arulselvi Anbalagan United States

Shenyi Yin China

Haiwen Ma China

Zhenchuan Liu

211 ×0.4

131 ×0.4

119 ×1.4

ONCOL

121 ×2.1

IMMUN

48 ×0.9

PRM

Citations per year, relative to Zhenchuan Liu Zhenchuan Liu (= 1×) peers Haiwen Ma

Countries citing papers authored by Zhenchuan Liu

Since Specialization

Citations

This map shows the geographic impact of Zhenchuan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenchuan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenchuan Liu more than expected).

Fields of papers citing papers by Zhenchuan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenchuan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenchuan Liu. The network helps show where Zhenchuan Liu may publish in the future.

Co-authorship network of co-authors of Zhenchuan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenchuan Liu. A scholar is included among the top collaborators of Zhenchuan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenchuan Liu. Zhenchuan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Liu, Zhenchuan, et al.. (2025). USP8 deubiquitylation-boosted NSUN4 potentiates lung squamous cell carcinoma progression by m5C methylation of DHCR24. Cell Reports. 44(8). 116158–116158.

Li, Lei, Yan Gao, Zhenchuan Liu, et al.. (2022). GDF11 alleviates neointimal hyperplasia in a rat model of artery injury by regulating endothelial NLRP3 inflammasome activation and rapid re-endothelialization. Journal of Translational Medicine. 20(1). 28–28. 11 indexed citations

Liu, Zhenchuan, Chenglai Dong, Shaorui Gu, et al.. (2022). MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway. Bioengineered. 13(6). 14064–14077. 3 indexed citations

Gu, Shaorui, Tiancheng Lu, Chenglai Dong, et al.. (2022). Feasibility evaluation of the transapical saddle‐shaped valved stent for transcatheter mitral valve implantation. Journal of Cardiac Surgery. 37(6). 1537–1543. 1 indexed citations

Liu, Zhenchuan, Tingting Wang, Yunlang She, et al.. (2021). N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Molecular Cancer. 20(1). 105–105. 267 indexed citations breakdown →

Wang, Tingting, Zhenchuan Liu, Yunlang She, et al.. (2021). A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis. Cancer Letters. 520. 321–331. 76 indexed citations

Liu, Zhenchuan, et al.. (2021). CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation. Journal of Experimental & Clinical Cancer Research. 40(1). 361–361. 43 indexed citations

Wang, Xiangyu, Hanjiang Zhao, Zhenchuan Liu, et al.. (2021). Polydopamine nanoparticles as dual-task platform for osteoarthritis therapy: A scavenger for reactive oxygen species and regulator for cellular powerhouses. Chemical Engineering Journal. 417. 129284–129284. 73 indexed citations

Gu, Shaorui, Haitao Huang, Chongjun Zhong, et al.. (2021). Upregulation of glucosamine‑phosphate N‑acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma. Oncology Letters. 21(6). 488–488. 10 indexed citations

10.

Liu, Zhenchuan, Kaiqing Wu, Shaorui Gu, et al.. (2021). A methyltransferase‐like 14/miR‐99a‐5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2‐mediated epigenetic modulation in esophageal squamous cell carcinoma. SHILAP Revista de lepidopterología. 11(9). e545–e545. 60 indexed citations

11.

Huang, Haitao, Shaorui Gu, Zhenchuan Liu, et al.. (2020). Long Noncoding RNA FAM225A Promotes Esophageal Squamous Cell Carcinoma Development and Progression via Sponging MicroRNA-197-5p and Upregulating NONO. Journal of Cancer. 12(4). 1073–1084. 10 indexed citations

12.

Liu, Zhenchuan, Shaorui Gu, Tiancheng Lu, et al.. (2020). IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress. Journal of Experimental & Clinical Cancer Research. 39(1). 144–144. 69 indexed citations

13.

Xu, Yangyang, Zhenchuan Liu, Ping Li, et al.. (2020). MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma. Journal of Experimental & Clinical Cancer Research. 39(1). 238–238. 18 indexed citations

14.

Liu, Zhenchuan, et al.. (2020). <p>MiRNA505/NET1 Axis Acts as a CD8<sup>+</sup> T-TIL Regulator in Non-Small Cell Lung Cancer</p>. OncoTargets and Therapy. Volume 13. 9785–9795. 5 indexed citations

15.

Liu, Zhenchuan, et al.. (2014). iPinYou Global RTB Bidding Algorithm Competition Dataset. 1–6. 44 indexed citations

16.

Chen, Mingyang, et al.. (2013). Segmentation of Cerebral Edema Around Spontaneous Intracerebral Hemorrhage. Applied Mathematics & Information Sciences. 7(2). 563–570. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact